Aug 8, 2020
What Is Favipiravir?
Favipiravir is also known as T-705, which is a new type of RNA polymerase inhibitor, was approved in Japan in March 2014 as another weapon for antiviral therapy for influenza A and B. Studies have shown that, in addition to influenza viruses, favipiravir may also exhibit good antiviral effects on a variety of RNA viruses, such as Ebola virus, sand virus, bunya virus, rabies virus, etc. The new coronavirus belongs to the coronavirus, is a positive chain single-stranded RNA virus with a coat membrane, and from the mechanism, favipiravir also has potential antiviral effects on the new coronavirus.
Contact us for more details: [email protected]. Tel: +8613682461609.
